Skip to main navigation Skip to search Skip to main content

LivaNova USA: Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure with Reduced Ejection Fraction (ANTHEM-HFrEF)

Project: Research

Project Details

StatusFinished
Effective start/end date05/9/1904/6/22

Funding

  • Cardiovascular Clinical Science Foundation: $23,557.04